Literature DB >> 33867743

Systemic Mastocytosis: Response to the Efficacy of Cladribine(2-CdA) with Current Terminology and Approach.

Irfan Yavaşoğlu1, Atakan Turgutkaya1.   

Abstract

Entities:  

Keywords:  Mastocytosis; Myeloproliferative; WHO

Year:  2020        PMID： 33867743      PMCID： PMC8012430          DOI： 10.1007/s12288-020-01332-6

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


× No keyword cloud information.
  4 in total

1.  Mayo alliance prognostic system for mastocytosis: clinical and hybrid clinical-molecular models.

Authors:  Animesh Pardanani; Sahrish Shah; Francesco Mannelli; Yoseph C Elala; Paola Guglielmelli; Terra L Lasho; Mrinal M Patnaik; Naseema Gangat; Rhett P Ketterling; Kaaren K Reichard; Curtis A Hanson; Alessandro M Vannucchi; Ayalew Tefferi
Journal:  Blood Adv       Date:  2018-11-13

2.  Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Jason Gotlib; Aaron T Gerds; Prithviraj Bose; Mariana C Castells; Michael W Deininger; Ivana Gojo; Krishna Gundabolu; Gabriela Hobbs; Catriona Jamieson; Brandon McMahon; Sanjay R Mohan; Vivian Oehler; Stephen Oh; Eric Padron; Philip Pancari; Nikolaos Papadantonakis; Animesh Pardanani; Nikolai Podoltsev; Raajit Rampal; Erik Ranheim; Lindsay Rein; David S Snyder; Brady L Stein; Moshe Talpaz; Swapna Thota; Martha Wadleigh; Katherine Walsh; Mary Anne Bergman; Hema Sundar
Journal:  J Natl Compr Canc Netw       Date:  2018-12       Impact factor: 11.908

3.  MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis.

Authors:  Mohamad Jawhar; Juliana Schwaab; Iván Álvarez-Twose; Khalid Shoumariyeh; Nicole Naumann; Johannes Lübke; Cecelia Perkins; Javier I Muñoz-González; Manja Meggendorfer; Vanessa Kennedy; Georgia Metzgeroth; Alice Fabarius; Dietmar Pfeifer; Karl Sotlar; Hans-Peter Horny; Nikolas von Bubnoff; Torsten Haferlach; Nicholas C P Cross; Wolf-Karsten Hofmann; Wolfgang R Sperr; Andrés C García-Montero; Peter Valent; Jason Gotlib; Alberto Orfao; Andreas Reiter
Journal:  J Clin Oncol       Date:  2019-09-11       Impact factor: 44.544
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.